Literature DB >> 12648317

Compliance with a protocol for intrapartum antibiotic prophylaxis against neonatal group B streptococcal sepsis in women with clinical risk factors.

Toni R Sanders1, Christine L Roberts, Gwendolyn L Gilbert.   

Abstract

OBJECTIVE: The aim of this study was to determine the prevalence of clinical risk factors (CRF) for neonatal sepsis in laboring women and to evaluate clinician compliance with a CRF-based protocol for intrapartum antibiotic prophylaxis (IAP).
METHODS: A retrospective chart audit was undertaken at a district hospital (A) and a tertiary obstetric hospital (B) in Sydney, Australia between 1996 and 1998, to determine compliance with IAP in women with defined CRF.
RESULTS: Eighty-five (12%) women at Hospital A and 117 (19%) at Hospital B had one or more CRF. Overall compliance rates with the IAP protocols were 65 and 50% at Hospitals A and B respectively, but varied according to maternal, obstetric and sepsis-related risk factors. We postulate that differences between the hospitals were related to protocol implementation.
CONCLUSIONS: Compliance with a CRF-based protocol was lower than previously reported. Improvements in protocol development, implementation and maintenance are required to enhance compliance with IAP based on CRF.

Entities:  

Mesh:

Year:  2002        PMID: 12648317      PMCID: PMC1784625          DOI: 10.1155/S1064744902000261

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  15 in total

1.  Guidelines, pathways, and the end result.

Authors:  H J DeMonaco
Journal:  Crit Care Med       Date:  2000-03       Impact factor: 7.598

2.  Audit of compliance with antenatal protocols.

Authors:  A F Yoong; J Lim; C N Hudson; T Chard
Journal:  BMJ       Date:  1992-11-14

3.  Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group.

Authors:  L A Bero; R Grilli; J M Grimshaw; E Harvey; A D Oxman; M A Thomson
Journal:  BMJ       Date:  1998-08-15

4.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

5.  Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections.

Authors:  D Isaacs; J A Royle
Journal:  Pediatr Infect Dis J       Date:  1999-06       Impact factor: 2.129

Review 6.  Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development.

Authors:  A Schuchat; J D Wenger
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

7.  Changing physician performance. A systematic review of the effect of continuing medical education strategies.

Authors:  D A Davis; M A Thomson; A D Oxman; R B Haynes
Journal:  JAMA       Date:  1995-09-06       Impact factor: 56.272

8.  Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis.

Authors:  S M Garland; J R Fliegner
Journal:  Aust N Z J Obstet Gynaecol       Date:  1991-05       Impact factor: 2.100

9.  Neonatal group B streptococcal sepsis during 2 years of a universal screening program.

Authors:  R S Gibbs; R S McDuffie; F McNabb; G E Fryer; T Miyoshi; G Merenstein
Journal:  Obstet Gynecol       Date:  1994-10       Impact factor: 7.661

10.  Attributes of clinical guidelines that influence use of guidelines in general practice: observational study.

Authors:  R Grol; J Dalhuijsen; S Thomas; C Veld; G Rutten; H Mokkink
Journal:  BMJ       Date:  1998-09-26
View more
  1 in total

1.  Compliance with protocols for prevention of neonatal group B streptococcal sepsis: practicalities and limitations.

Authors:  Gwendolyn L Gilbert; Moira C Hewitt; Catherine M Turner; Stephen R Leeder
Journal:  Infect Dis Obstet Gynecol       Date:  2003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.